Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Liver Cirrhosis

  Free Subscription


Articles published in Z Gastroenterol

Retrieve available abstracts of 21 articles:
HTML format
Text format



Single Articles


    January 2020
  1. MICHEL M, Kalliga E, Labenz C, Straub BK, et al
    A young patient with type 2 diabetes associated non-alcoholic steatohepatitis, liver cirrhosis, and hepatocellular carcinoma.
    Z Gastroenterol. 2020;58:57-62.
    PubMed     Text format     Abstract available


    December 2019
  2. GUNDLING F, Rathmayer M, Koller L, Wilke M, et al
    [Prognostic significance and economic burden of hepatic encephalopathy in liver cirrhosis in German hospitals based on G-DRG data].
    Z Gastroenterol. 2019 Dec 20. doi: 10.1055/a-1068-3138.
    PubMed     Text format     Abstract available


    October 2019
  3. ALSENBESY M, Rau M, Weiss J, Gotze O, et al
    A 2-step fast-track elastometry service for advanced workup of nonalcoholic fatty liver disease (NAFLD) patients - single-center real-world experience of outpatient clinical practice.
    Z Gastroenterol. 2019;57:1209-1217.
    PubMed     Text format     Abstract available


    August 2019
  4. OCHS K, Heinzow HS
    [The Clif-Consortium strikes again: Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe].
    Z Gastroenterol. 2019;57:997-999.
    PubMed     Text format    


  5. HOLSTEGE A
    [Long-term drug treatments to improve prognosis of patients with liver cirrhosis and to prevent complications due to portal hypertension].
    Z Gastroenterol. 2019;57:983-996.
    PubMed     Text format     Abstract available


  6. HENTSCHEL F, Bornscheuer T, Luth S
    [Secondary cholangitis of the critically ill].
    Z Gastroenterol. 2019;57:977-982.
    PubMed     Text format     Abstract available


    July 2019
  7. WREE A, Geisler LJ, Tacke F
    [Microbiome & NASH - partners in crime driving progression of fatty liver disease].
    Z Gastroenterol. 2019;57:871-882.
    PubMed     Text format     Abstract available


    June 2019
  8. HORVATITS T, Drolz A, Wehmeyer M, Steib C, et al
    [Proton pump inhibitors in patients with liver cirrhosis - a survey among hepatologists in Germany].
    Z Gastroenterol. 2019;57:729-733.
    PubMed     Text format     Abstract available


    May 2019
  9. GERBES AL, Labenz J, Appenrodt B, Dollinger M, et al
    [Updated S2k-Guideline "Complications of liver cirrhosis". German Society of Gastroenterology (DGVS)].
    Z Gastroenterol. 2019 May 6. doi: 10.1055/a-0873-4658.
    PubMed     Text format     Abstract available


  10. GERBES AL, Labenz J, Appenrodt B, Dollinger M, et al
    [Updated S2k-Guideline "Complications of liver cirrhosis". German Society of Gastroenterology (DGVS)].
    Z Gastroenterol. 2019;57:e168.
    PubMed     Text format    


    April 2019
  11. ROEB E, Geier A
    Nonalcoholic steatohepatitis (NASH) - current treatment recommendations and future developments.
    Z Gastroenterol. 2019;57:508-517.
    PubMed     Text format     Abstract available


    February 2019
  12. MAUSS S, Buendgens L, Christensen S, Ingiliz P, et al
    Risk factors for remaining liver injury in patients with virological elimination of chronic hepatitis C.
    Z Gastroenterol. 2019;57:139-147.
    PubMed     Text format     Abstract available


    October 2018
  13. KARLAS T
    [Elastography characteristics of liver lesions - a new diagnostic tool?]
    Z Gastroenterol. 2018;56:1283-1284.
    PubMed     Text format    


    June 2018
  14. LINDNER F, Muhlberg R, Wiegand J, Troltzsch M, et al
    Predictive value of liver and spleen stiffness in advanced alcoholic cirrhosis with refractory ascites.
    Z Gastroenterol. 2018;56:561-568.
    PubMed     Text format     Abstract available


    January 2018
  15. KARKMANN K, Piecha F, Runzi AC, Schulz L, et al
    [Management of compensated liver cirrhosis 2018 - Evidence based prophylactic measures].
    Z Gastroenterol. 2018;56:55-69.
    PubMed     Text format     Abstract available


    November 2017
  16. KLINGER C, Riecken B, Schmidt A, De Gottardi A, et al
    Transjugular portal vein recanalization with creation of intrahepatic portosystemic shunt (PVR-TIPS) in patients with chronic non-cirrhotic, non-malignant portal vein thrombosis.
    Z Gastroenterol. 2017 Nov 7. doi: 10.1055/s-0043-121348.
    PubMed     Text format     Abstract available


    June 2017
  17. SCHLEVOGT B, Heinzow HS
    [Testosterone treatment for patients with sarcopenia and liver cirrhosis].
    Z Gastroenterol. 2017;55:594-595.
    PubMed     Text format    


  18. LANKISCH TO
    [Unplanned hospitalization in the end stage of liver cirrhosis: predictable or not?]
    Z Gastroenterol. 2017;55:592-593.
    PubMed     Text format    


    February 2017
  19. SEEHOFER D, Sucher R, Schmelzle M, Ollinger R, et al
    Evolution of laparoscopic liver surgery as standard procedure for HCC in cirrhosis?
    Z Gastroenterol. 2017 Feb 27. doi: 10.1055/s-0043-100021.
    PubMed     Text format     Abstract available


    October 2016
  20. BUECHTER M, Theysohn JM, Kahraman A, Manka P, et al
    Rescue therapy of a refractory rectal variceal bleeding in a cirrhotic patient by Linton-Nachlas tube and TIPS implantation in combination with variceal embolization.
    Z Gastroenterol. 2016.
    PubMed     Text format     Abstract available


    August 2016
  21. DIKOPOULOS N, Zizer E
    [Coincidence of a chronic Hepatitis C and an autoimmune Hepatitis Type 3 - successful therapy with the new direct-acting antiviral agents].
    Z Gastroenterol. 2016;54:770-3.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Cirrhosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: